TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive ‘Interactive Research Project Grants’ Proposed, Goal To Provide Step Between R01s and P01s October 25, 1991
TCL Archive In Brief: Knowledge Surgeons, Radiotherapists, Pathologists Untapped, Zubrod Suggests February 20, 1976
TCL Archive In Brief: Carcinogenesis: Does The Promise Justify The Effort? Task Force Attempts To Find Out September 30, 1977
